1. Acknowledgement to Referees

   Acknowledgement to Referees 14 December 2021 Pages: 1 - 4

2. CHEERS to 30 Years of PharmacoEconomics

   • Richard Milne
   • Christopher Carswell

   Editorial 18 December 2021 Pages: 5 - 6

3. In Absence of Absenteeism: Some Thoughts on Productivity Costs in Economic Evaluations in a Post-corona Era

   • Werner Brouwer
   • Samare Huls
   • Job van Exel

   Editorial 16 December 2021 Pages: 7 - 11

4. The Challenges of Outcomes-Based Contract Implementation for Medicines in Europe

   • Natalie Bohm
   • Sarah Bermingham
   • Hamish Laing

   Review Article Open access 04 September 2021 Pages: 13 - 29

   

5. Empirical Estimates of the Marginal Cost of Health Produced by a Healthcare System: Methodological Considerations from Country-Level Estimates

   • Laura C. Edney
   • James Lomas
   • Jessica Ochalek

   Review Article 29 September 2021 Pages: 31 - 43

   

6. Incorporating Equity Concerns in Cost-Effectiveness Analyses: A Systematic Literature Review

   • Thomas Ward
   • Ruben E. Mujica-Mota
   • Antonieta Medina-Lara

   Systematic Review 29 October 2021 Pages: 45 - 64

   

7. A General Public Study on Preferences and Welfare Impacts of Antimicrobial Resistance in the United Kingdom

   • Maria Veronica Dorgali
   • Alberto Longo
   • Marco Boeri

   Original Research Article 30 August 2021 Pages: 65 - 76

   

8. Productivity of Working at Home and Time Allocation Between Paid Work, Unpaid Work and Leisure Activities During a Pandemic

   • Samare P. I. Huls
   • Ayesha Sajjad
   • Job van Exel

   Original Research Article Open access 02 September 2021 Pages: 77 - 90

   

9. The Potential Cost-Effectiveness of a Cell-Based Bioelectronic Implantable Device Delivering Interferon-β1a Therapy Versus Injectable Interferon-β1a Treatment in Relapsing–Remitting Multiple Sclerosis

   • Laurenske A. Visser
   • Marc Folcher
   • William Ken Redekop

   Original Research Article Open access 04 September 2021 Pages: 91 - 108

   

10. Biased Survival Predictions When Appraising Health Technologies in Heterogeneous Populations

    • Daniel Gallacher
    • Peter Kimani
    • Nigel Stallard

    Original Research Article Open access 28 September 2021 Pages: 109 - 120

    

11. An Integrated Pharmacokinetic–Pharmacodynamic–Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia

    • Marjanne A. Piena
    • Natalie Houwing
    • Craig Bennison

    Original Research Article Open access 08 October 2021 Pages: 121 - 131

    

12. Preoperative Intravenous Iron for Iron Deficiency is Cost-Effective Prior to Major Elective Surgery

    • Kevin M. Trentino
    • Hamish Mace
    • Axel Hofmann

    Letter to the Editor 15 September 2021 Pages: 133 - 135

13. Authors’ Response to “Preoperative Intravenous Iron for Iron Deficiency is Cost-Effective Prior to Major Elective Surgery”

    • Bert Avau
    • Hans Van Remoortel
    • Philippe Vandekerckhove

    Letter to the Editor 15 September 2021 Pages: 137 - 138

14. Correction to: A Comparison of the SF-6Dv2 and SF-6D UK Utility Values in a Mixed Patient and Healthy Population

    • Emily McDool
    • Clara Mukuria
    • John Brazier

    Correction Open access 25 November 2021 Pages: 139 - 139